CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...